JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 3 filers reported holding JUNO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $11,000 | +22.2% | 250 | +25.0% | 0.01% | +16.7% |
| Q3 2017 | $9,000 | -18.2% | 200 | -60.0% | 0.01% | -14.3% |
| Q1 2017 | $11,000 | +22.2% | 500 | 0.0% | 0.01% | +40.0% |
| Q4 2016 | $9,000 | -40.0% | 500 | 0.0% | 0.01% | -44.4% |
| Q3 2016 | $15,000 | -21.1% | 500 | 0.0% | 0.01% | -18.2% |
| Q2 2016 | $19,000 | +26.7% | 500 | +25.0% | 0.01% | +37.5% |
| Q1 2016 | $15,000 | +15.4% | 400 | +33.3% | 0.01% | +14.3% |
| Q4 2015 | $13,000 | +116.7% | 300 | +100.0% | 0.01% | +133.3% |
| Q3 2015 | $6,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,864,174 | $85,211,000 | 94.86% |
| Crestline Management, LP | 7,631,631 | $348,841,000 | 35.74% |
| Omega Fund Management, LLC | 753,564 | $34,445,000 | 24.90% |
| DDD Partners, LLC | 191,458 | $8,752,000 | 3.40% |
| SIB LLC | 100,000 | $4,571,000 | 3.28% |
| PECONIC PARTNERS LLC | 433,587 | $19,819,000 | 2.85% |
| Cormorant Asset Management, LP | 550,000 | $25,141,000 | 2.63% |
| ARK Investment Management | 682,495 | $31,197,000 | 2.48% |
| BB BIOTECH AG | 1,925,000 | $87,992,000 | 2.48% |
| Clarius Group, LLC | 120,988 | $5,530,000 | 2.47% |